Trial · NCT04092530
Linking Inter-professional Newborn and Contraception Care
NCT04092530, Not applicable, Completed, Rush University Medical Center; results first posted 2025-09-04
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Linking Inter-professional Newborn and Contraception Care. Trials, record NCT04092530. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04092530
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Linking Inter-professional Newborn and Contraception Care
- NCT number
- NCT04092530
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 2,518 participants, actual
- Lead sponsor
- Rush University Medical Center
- Conditions
- Family Planning, Contraception, PostPartum
- Interventions
- LINCC intervention - enable co-schedule feature
- First posted
- 2019-09-17
- Last updated
- 2025-09-04
- Results first posted
- 2025-09-04
Source ClinicalTrials.gov
Registered outcomes3
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Patients Who Receive Contraception by Two Months Postpartum | 2 months | Using de-identified patient data collected through clinic's Electronic Health Record (EHR) system (i.e., visit type attended, billing codes for contraception) we will measure receipt of all methods of contraception by two months postpartum |
| Secondary | Number of Patients Who Receive Contraception by Six Months Postpartum | 6 months | Using de-identified patient data collected through clinic's Electronic Medical Record system (i.e., visit type attended, billing codes for contraception) we will measure receipt of all methods of contraception by six months postpartum |
| Secondary | Number of Patients Who Present With a Short Inter-pregnancy Interval Pregnancies | 12 months | Use EHR data to follow up participants for short IPI (subsequent pregnancy before 12 months postpartum) |
Source ClinicalTrials.gov
Outcomes3
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Patients Who Receive Contraception by Two Months Postpartum | 2 months | No difference | Participants | NUMBER |
| SECONDARY | Number of Patients Who Receive Contraception by Six Months Postpartum | 6 months | The stepped wedge design was interrupted for outcomes measured at six months due to a longer washout period, resulting in slightly different, yet overlapping samples for the primary and secondary outcomes. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Patients Who Present With a Short Inter-pregnancy Interval Pregnancies | 12 months | Due to a shortened study period because of interruptions related to the COVID-19 pandemic, this outcome was measured at 12 instead of 18 months postpartum. Two clinical sites changed to a new EHR platform before the end of the 12 month follow up period, disrupting follow up and leading to fewer numbers of participants in the intervention condition. | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.gov
Results by group6
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Patients Who Receive Contraception by Two Months Postpartum | Intervention - Aim 2 | 474 | Participants | ||
| Number of Patients Who Receive Contraception by Two Months Postpartum | Control - Aim 2 | 339 | Participants | ||
| Number of Patients Who Receive Contraception by Six Months Postpartum | Intervention - Aim 2 | 595 | Participants | ||
| Number of Patients Who Receive Contraception by Six Months Postpartum | Control - Aim 2 | 436 | Participants | ||
| Number of Patients Who Present With a Short Inter-pregnancy Interval Pregnancies | Intervention - Aim 2 | 67 | Participants | ||
| Number of Patients Who Present With a Short Inter-pregnancy Interval Pregnancies | Control - Aim 2 | 55 | Participants |
Source ClinicalTrials.gov
Participant flow189
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Period 1: Months 1-3 | STARTED | Sequence/Clinic 1: 3 Months Baseline, 21 Months Intervention | 82 | 1 |
| Period 1: Months 1-3 | STARTED | Sequence/Clinic 2: 6 Months Baseline, 18 Months Intervention | 50 | 1 |
| Period 1: Months 1-3 | STARTED | Sequence/Clinic 3: 9 Months Baseline, 15 Months Intervention | 68 | 1 |
| Period 1: Months 1-3 | STARTED | Sequence/Clinic 4: 12 Months Baseline, 12 Months Intervention | 32 | 1 |
| Period 1: Months 1-3 | STARTED | Sequence/Clinic 5: 15 Months Baseline, 9 Months Intervention | 52 | 1 |
| Period 1: Months 1-3 | STARTED | Sequence/Clinic 6: 18 Months Baseline, 6 Months Intervention | 17 | 1 |
| Period 1: Months 1-3 | STARTED | Sequence/Clinic 7: 21 Months Baseline, 3 Months Intervention | 12 | 1 |
| Period 1: Months 1-3 | COMPLETED | Sequence/Clinic 1: 3 Months Baseline, 21 Months Intervention | 82 | 1 |
| Period 1: Months 1-3 | COMPLETED | Sequence/Clinic 2: 6 Months Baseline, 18 Months Intervention | 50 | 1 |
| Period 1: Months 1-3 | COMPLETED | Sequence/Clinic 3: 9 Months Baseline, 15 Months Intervention | 68 | 1 |
1 to 10 of 189Source ClinicalTrials.gov
See all 189 participant flowAdverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Experimental: Intervention - Aim 2 | 0 | 1,497 |
| Total, all-cause mortality | Control - Aim 2 | 0 | 1,021 |
| Total, other adverse events | Experimental: Intervention - Aim 2 | 0 | 1,497 |
| Total, other adverse events | Control - Aim 2 | 0 | 1,021 |
| Total, serious adverse events | Experimental: Intervention - Aim 2 | 0 | 1,497 |
| Total, serious adverse events | Control - Aim 2 | 0 | 1,021 |
Source ClinicalTrials.gov
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 39121991 | DERIVED |
Source PubMed
Grants1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years |
|---|---|---|---|---|---|
| R01HD097171 | Linking Inter-professional Newborn and Contraception Care (LINCC) Trial - A Novel Approach to Postpartum Contraception Provision at the Well-Baby Visit | HAIDER, SADIA; CASKEY, RACHEL | RUSH UNIVERSITY MEDICAL CENTER | EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT | 2019 to 2023 |
Source NIH RePORTER
Trial comparisons5
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Intervention - Aim 2 vs Control - Aim 2: Number of Patients Who Receive Contraception by Six Months Postpartum | Trial comparisons |
| Intervention - Aim 2 vs Control - Aim 2: Number of Patients Who Present With a Short Inter-pregnancy Interval Pregnancies | Trial comparisons |
| Intervention - Aim 2 vs Control - Aim 2: Number of Patients Who Receive Contraception by Two Months Postpartum | Trial comparisons |
| Experimental: Intervention - Aim 2 vs Control - Aim 2: deaths from any cause | Trial comparisons |
| Experimental: Intervention - Aim 2 vs Control - Aim 2: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04092530
GET https://conductscience.org/api/trials/v1/NCT04092530/flow?page=2